Outbrain GLP-1 ads run through approval agreed directly with the network. Outbrain’s public advertiser guidelines list prescription drugs as a prohibited category and publish no GLP-1 or telehealth exception, so the public text is only part of the picture. Approved or not, every campaign still follows Outbrain’s health-claim, image and landing-page rules.
Policy checked on October 29, 2026.
What Outbrain’s guidelines say about prescription drugs
Outbrain’s guidelines put prescription drugs under “Controlled or Illegal Substances” in the Prohibited Categories list. The rule reads:
“Ads must not promote the sale or use of illegal, prescription, or recreational drugs.”
Source: Outbrain, Our Advertising Guidelines. The page carries no “last updated” date.
Three more facts from the same page matter to a GLP-1 brand:
- The rules bind advertisers that contracted “Outbrain Inc. (recently renamed Teads Holding Co.) and Outbrain UK Limited.” The rename was completed on June 9, 2025, according to PPC Land. The ad platform still runs as Outbrain.
- Review continues after launch. Outbrain says it can “reject or block any content for any reason at our sole discretion, even after post-launch.”
- Violations earn “red flag warnings (communicated to you via email)”. Repeat or severe violations can get an account, content or campaigns suspended or banned.
Outbrain’s managed-account and verification clauses
Outbrain’s guidelines let a few named categories run only from managed accounts verified by Outbrain’s team. The wording appears under Tobacco products and under Cryptocurrency:
“Such offers can be promoted by managed accounts only, and upon verification by our team.”
Under Financial Services, the line reads “CFDs and Forex can be promoted by managed accounts only, and upon verification by the our team.” Outbrain’s rejection help page says gambling is “only open to managed accounts,” and only “after the offer has been pre-approved upon submitted proper documentation.”
These clauses cover tobacco, cryptocurrency, CFDs and Forex, and gambling. None of them names prescription drugs, health or telehealth, so they are not a published route for GLP-1 ads.
Outbrain’s parent company publishes a separate healthcare policy for Teads inventory. It states: “Advertisements for prescription medication shall be evaluated on a case by case basis by Teads.” For the United States it adds that prescription drug ads “may only contain factual information on the product” and “may not make any claims about the drug or its effectivity” (Teads healthcare guidelines).
For a GLP-1 telehealth brand, getting onto Outbrain is a question of approval agreed directly with the network. We run GLP-1 and telehealth traffic at scale with platform approvals on every network we buy.
GLP-1 ads on Outbrain: allowed and not allowed
Outbrain’s health, image, headline and landing-page rules apply to every campaign, approved or not. This table maps them to the elements of a GLP-1 telehealth campaign.
| Campaign element | What Outbrain accepts | What Outbrain rejects (its wording) |
|---|---|---|
| Drug names and drug images | Outbrain publishes no permission for drug-name ads or drug imagery | Ads that “promote the sale or use of… prescription… drugs”; thumbnails with “Drugs or drug paraphernalia” |
| Health claims | Softer verbs Outbrain lists, such as “Relieve”, “Improve”, “Reduce” | Claims that “allude to diagnose, cure, prevent, treat, or reverse any disease, condition, or illness” |
| Weight-loss headlines | Headlines that match the landing page | “Too good to be true” headlines (Outbrain’s example: “One weird trick that will help you lose that belly fat”) |
| Thumbnails | Clear, relevant, unedited images | “Before/After Photos”, “Zoomed in body parts”, “Graphic images of physical deformities or health conditions” |
| AI creative | Content “clearly labelled as AI-generated at the point of first exposure” | AI used to “fabricate testimonials” or “produce synthetic ‘before and after’ imagery” |
| Advertorial pages | “Advertisement” or “Advertorial” shown “clearly and prominently at the top” | Pages that make readers think they are “reading legitimate editorial content” |
| Comparison and affiliate pages | Pages that “clearly disclose any financial relationship” with the advertiser | Fake testimonials, fake comments, fake earned media logos |
| Urgency | Real offers with real end dates | “Countdown clocks that make a user think the offer expires (when it doesn’t)” |
| Audience | Adults | “No content targeted to children under the age of 18” |
| Landing page basics | A Privacy Policy link and a Contact Us section with “an actual email address, phone number, or physical address” | “An empty form to email the site owners” |
Outbrain rejection reasons GLP-1 campaigns hit
Outbrain’s help page lists every rejection reason with a fix and a yes/no on resubmitting the same ads. These are the reasons that apply to a GLP-1 health campaign.
| Rejection reason | What Outbrain says it means | Resubmit after a fix? |
|---|---|---|
| Controlled Substances | The ad “promotes illegal, prescription, or recreational drugs” | No |
| Sensational (headline) | “Absolute or misleading health claims” or “overpromising claims” | Yes |
| Images: Prohibited | Includes “Before and after images” and “Cannabis leaves, drugs” | Yes |
| Absolute or misleading claims (landing page) | Terms such as “Cure”, “Treat”, “Reverse”, “Get rid of” | Yes |
| Misleading advertising techniques | Before/after images without a “results may vary” disclaimer, countdown clocks, unlinked media logos | Yes |
| Missing advertorial disclosure | The disclosure is not “visibly located at the top of the page” | Yes |
| Missing Privacy Policy or Contact Us | Missing section, or a link that returns a 404 | Yes |
A “No” means the same ads cannot go back into review, so a new ad has to be built. For the “Yes” reasons, the official route is to fix the headline, image or page and resubmit.
What a GLP-1 brand needs in place for Outbrain campaigns
Network approval covers the traffic source. The GLP-1 brand still owns everything the ad points to:
- A compliant telehealth operation, with licensed prescribers and the state coverage the brand claims. Teads’ US rule (factual information only, no claims about a drug’s effectiveness) is a fair standard for any page that mentions a medication.
- Certification where a network names it. Outbrain’s public pages don’t name LegitScript. Meta requires telehealth providers to be actively certified with LegitScript, and TikTok’s US policy asks pharmacies for NABP or LegitScript certification, so a brand that buys several channels usually needs it anyway. See our LegitScript guide and Meta’s prescription drug rules.
- Claims that hold up: no cure or reversal language, no “too good to be true” results, and no compounded-drug claims the FDA has flagged. Our page on misleading GLP-1 ad claims covers those.
- A landing page Outbrain will pass, with the advertorial label at the top, a financial-relationship disclosure on comparison pages, a working privacy policy and real contact details.
- Adult targeting. Outbrain bars content aimed at anyone under 18.
Why GLP-1 telehealth brands use Outbrain
Outbrain places ads in recommendation feeds under articles on news and content sites. After the merger, PPC Land reported that the combined platform has direct partnerships with more than 10,000 publishers and serves more than 20,000 advertisers (PPC Land, June 9, 2025).
Readers arrive from an article, so native traffic usually needs an article-style page between the ad and the offer. That page has to carry the advertorial label and follow the claims rules above. Brands that also buy Taboola meet a similar setup there: see Taboola ads for GLP-1 brands.
FAQ
Does Outbrain allow prescription drug ads?
Outbrain’s public guidelines list prescription drugs as prohibited and publish no telehealth exception. Outbrain also runs managed accounts with verification for other restricted categories, and its parent Teads reviews prescription medication ads case by case. GLP-1 brands reach Outbrain through network approval.
Is Outbrain now Teads?
The company Outbrain Inc. renamed itself Teads Holding Co. on June 9, 2025. Outbrain’s guidelines page now carries Teads branding, and the ad platform still operates as Outbrain.
Can GLP 1 telehealth brands run native ads without LegitScript?
Outbrain’s public guidelines don’t mention LegitScript. Meta requires telehealth providers to be actively certified with LegitScript, and TikTok’s US policy asks pharmacies for NABP or LegitScript certification, so a brand that buys several channels usually needs it anyway.
Can I resubmit a rejected Outbrain ad?
It depends on the reason. Outbrain’s help page says headline, image and landing-page rejections can be resubmitted after a fix. Controlled Substances rejections cannot.
Sources
- Outbrain, Our Advertising Guidelines (prohibited and restricted categories, landing page, headline, image, AI and strike policy; no date on page) · accessed
- Outbrain Help Center, Why was my content rejected? (rejection reasons, fixes, resubmit yes/no, managed accounts) · accessed
- Teads, Healthcare, Pharmacies and Medications Specific Guidelines (prescription medication case by case; United States rules) · accessed
- Meta Transparency Center, Advertising Standards: Drugs and Pharmaceuticals (online pharmacies and telehealth providers must be actively certified with LegitScript) · accessed
- TikTok Business Help Center, Healthcare and pharmaceuticals ad policy (United States, Pharmacies: certification by NABP or LegitScript) · accessed
- PPC Land, Outbrain completes transformation to Teads brand with new ticker symbol (June 9, 2025; 10,000+ publishers, 20,000+ advertisers) · accessed